Literature DB >> 7683256

Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.

J P de Boer1, A A Creasy, A Chang, D Roem, M C Brouwer, A J Eerenberg, C E Hack, F B Taylor.   

Abstract

Administration of low doses endotoxin or tumor necrosis factor (TNF) in human experimental models for sepsis results in transient activation of both coagulation and fibrinolysis and subsequent inhibition of the fibrinolytic system by plasminogen activator inhibitor type 1 (PAI-1). We have investigated in a baboon model for sepsis, whether administration of a lethal or sublethal dose of living E. coli could induce similar activation patterns. Levels of thrombin-antithrombin III (TAT) complexes increased significantly to zeniths of 425 and 33 times the baseline values at t+360 in the lethal and sublethal group, respectively. Activation of fibrinolysis, as reflected by plasmin-alpha 2 antiplasmin (PAP) complexes, in the sublethal group was maximal at t+60 and was increasingly inhibited thereafter in spite of a sustained increase of tissue type plasminogen activator (t-PA) levels. In the lethal group PAP complexes increased to a zenith of 38 times the baseline values at t+240. PAI-1 levels increased to 15 times the baseline values at t+360 in the sublethal group, whereas in the lethal group they increased almost linearly to 20 times the baseline values at t+360. Despite high levels of PAI-1, effective inhibition of the fibrinolysis was not established until at T+240 in the lethal group. The difference in activation patterns of both mediator systems in the sublethal and lethal group of baboons indicate that extensive activation of coagulation contributes to the lethal complications in sepsis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683256

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  11 in total

Review 1.  The protein C pathway and pathologic processes.

Authors:  F J Castellino; V A Ploplis
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

2.  Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

Authors:  F B Taylor; V L Tesh; L DeBault; A Li; A C Chang; S D Kosanke; T J Pysher; R L Siegler
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis.

Authors:  Ravi Shankar Keshari; Robert Silasi; Narcis Ioan Popescu; Maulin Mukeshchandra Patel; Hala Chaaban; Cristina Lupu; K Mark Coggeshall; Tom Eirik Mollnes; Steven J DeMarco; Florea Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

4.  Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.

Authors:  J P de Boer; A A Creasey; A Chang; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

Authors:  J P de Boer; A A Creasey; A Chang; J J Abbink; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 6.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.

Authors:  C Lupu; O Herlea; H Tang; R H Lijnen; F Lupu
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

8.  Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.

Authors:  Haiwang Tang; Lacramioara Ivanciu; Narcis Popescu; Glenn Peer; Erik Hack; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

9.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Authors:  A A Creasey; A C Chang; L Feigen; T C Wün; F B Taylor; L B Hinshaw
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 10.  Pathophysiology, staging and therapy of severe sepsis in baboon models.

Authors:  Fletcher B Taylor; Gary T Kinasewitz; Florea Lupu
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.